Inventaire - your friends and communities are your best library

Bladder cancer

published in: The Lancet

date of publication: 2009-06-10

language: English

Cites articles 91

Date

Title

Authors

2008-06-01

The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy
2008-01-25

Outcome after radical cystectomy with limited or extended pelvic lymph node dissection
2008-12-18

Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemoth
2008-04-01

Positive response to bevacizumab in a patient with metastatic, chemotherapy-refractory urothelial carcinoma
2008-01-01

Prognostic significance of Her2/neu overexpression in patients with muscle invasive urinary bladder cancer treated with radical cystectomy

Rajeev Kumar
2007-01-01

Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?

Sherri Donat, Guido Dalbagni
2007-08-14

Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
2007-04-01

Urinary diversion: options, patient selection, and outcomes

Sherri Donat
2007-09-18

Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions
2007-01-01

EGFR, HER2 and VEGF pathways: validated targets for cancer treatment

Heinz-Josef Lenz
2007-09-01

Targeted therapies in bladder cancer--an update
2007-06-01

Trastuzumab, paclitaxel, carboplatin, and gemcitabine in advanced human epidermal growth factor receptor-2/neu-positive urothelial carcinoma: results of a multicenter phase II National Cancer Institute trial

David C. Smith
2006-03-01

Genetic alterations in urothelial bladder carcinoma: an updated review
2006-07

Arsenic cancer risk confounder in southwest Taiwan data set
2006-03-23

The value of a second transurethral resection for T1 bladder cancer
2006-01-17

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.
2006-11-01

Neoadjuvant chemotherapy for bladder cancer
2006-07-01

Phase II study of pemetrexed for second-line treatment of transitional cell cancer of the urothelium
2006-04-01

Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q

Thoas Fioretos, Mattias Höglund, Anna K Hagström-Andersson, Sigurdur Gudjonsson
2005-12-01

Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers
2005-02-01

Detection of bladder cancer using a point-of-care proteomic assay

Yu Shen, Mark Soloway
2005-01-01

ImmunoCyt/uCyt+ improves the sensitivity of urine cytology in patients followed for urothelial carcinoma
2005-03-23

Urine markers for bladder cancer surveillance: a systematic review.
2005-05-01

Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder

Sanaa Eissa, Pierre I Karakiewicz, Paul Perrotte, Hartwig Huland, Shahrokh Shariat, Claus G Roehrborn, Serge Benayoun, Yair Lotan, Arthur I. Sagalowsky, Vincenzo Serretta, Marta Sanchez-Carbayo, Craig Zippe, Gerson Lüdecke, Christine Mian, Hans Hedelin, Naoto Miyanaga, Rupesh Raina
2005-01-01

Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates--the Massachusetts General Hospital and Radiation Therapy Oncology Group experiences
2005-01-01

Management of muscle invasive bladder cancer--British approaches to organ conservation

Syed A. Hussain
2005-04-21

Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration
2005-04-01

Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling

Toyomasa Katagiri
2005-06-01

Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium

John D Hainsworth
2005-06-01

Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group
2004-11-01

Inactivation of the FHIT gene favors bladder cancer development

Carlo Maria Croce
2004-09-16

Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging

Christina A Hulsbergen-van de Kaa

Article - wd:Q84058686

Welcome to Inventaire

the library of your friends and communities

learn more